ProfileGDS4718 / 218796_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 95% 74% 96% 95% 99% 96% 93% 96% 96% 97% 91% 98% 99% 95% 95% 96% 99% 98% 95% 97% 96% 95% 96% 97% 99% 96% 97% 95% 99% 95% 99% 90% 96% 96% 98% 97% 95% 94% 40% 94% 98% 99% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.928997
GSM549102patient 115, normal, homogenized [OPG study]10.273395
GSM549104patient 119, normal, homogenized [OPG study]7.2700774
GSM549108patient 138, normal, homogenized [OPG study]10.466596
GSM549119patient 077, normal, homogenized [OPG study]10.336395
GSM549133patient 032, cancer, homogenized [OPG study]11.938599
GSM549139patient 042, cancer, homogenized [OPG study]10.584496
GSM549099patient 107, normal, homogenized [OPG study]9.7850293
GSM549109patient 139, normal, homogenized [OPG study]10.722496
GSM549110patient 046, normal, homogenized [OPG study]10.692496
GSM549114patient 063, normal, homogenized [OPG study]11.420797
GSM549122patient 082, normal, homogenized [OPG study]9.4566991
GSM549134patient 033, cancer, homogenized [OPG study]11.319998
GSM549136patient 036, cancer, homogenized [OPG study]12.855999
GSM549140patient 044, cancer, homogenized [OPG study]10.288595
GSM549111patient 047, normal, homogenized [OPG study]10.456295
GSM549113patient 057, normal, homogenized [OPG study]10.718996
GSM549132patient 031, cancer, homogenized [OPG study]11.675199
GSM549137patient 038, cancer, homogenized [OPG study]11.426698
GSM549142patient 047, cancer, homogenized [OPG study]9.7739795
GSM549100patient 110, normal, homogenized [OPG study]11.035797
GSM549107patient 135, normal, homogenized [OPG study]10.588196
GSM549115patient 068, normal, homogenized [OPG study]10.596395
GSM549116patient 072, normal, homogenized [OPG study]10.588596
GSM549120patient 078, normal, homogenized [OPG study]10.994597
GSM549131patient 030, cancer, homogenized [OPG study]12.123799
GSM549118patient 074, normal, homogenized [OPG study]10.466796
GSM549129patient 027, cancer, homogenized [OPG study]10.69697
GSM549123patient 088, normal, homogenized [OPG study]10.24395
GSM549124patient 006, cancer, homogenized [OPG study]11.748499
GSM549126patient 015, cancer, homogenized [OPG study]10.250495
GSM549128patient 025, cancer, homogenized [OPG study]12.204799
GSM549103patient 117, normal, homogenized [OPG study]9.1797590
GSM549117patient 073, normal, homogenized [OPG study]10.852196
GSM549138patient 041, cancer, homogenized [OPG study]10.662996
GSM549141patient 045, cancer, homogenized [OPG study]11.205298
GSM549130patient 028, cancer, homogenized [OPG study]10.686997
GSM549101patient 111, normal, homogenized [OPG study]10.29895
GSM549105patient 128, normal, homogenized [OPG study]9.9186794
GSM549106patient 134, normal, homogenized [OPG study]4.9522740
GSM549112patient 048, normal, homogenized [OPG study]10.036494
GSM549125patient 011, cancer, homogenized [OPG study]11.425298
GSM549127patient 024, cancer, homogenized [OPG study]11.688499
GSM549135patient 035, cancer, homogenized [OPG study]10.627396